The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, VYNE Therapeutics Inc’s stock clocked out at $1.72, up 2.38% from its previous closing price of $1.68. In other words, the price has increased by $2.38 from its previous closing price. On the day, 0.85 million shares were traded. VYNE stock price reached its highest trading level at $1.8498 during the session, while it also had its lowest trading level at $1.63.
Ratios:
To gain a deeper understanding of VYNE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.35 and its Current Ratio is at 4.35. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on November 18, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 15 ’25 when LEPORE PATRICK G bought 15,000 shares for $2.92 per share. The transaction valued at 43,800 led to the insider holds 51,472 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VYNE now has a Market Capitalization of 26161028 and an Enterprise Value of -35256036. For the stock, the TTM Price-to-Sale (P/S) ratio is 52.32 while its Price-to-Book (P/B) ratio in mrq is 0.49. Its current Enterprise Value per Revenue stands at -70.371 whereas that against EBITDA is 0.808.
Stock Price History:
The Beta on a monthly basis for VYNE is 1.35, which has changed by -0.3036437 over the last 52 weeks, in comparison to a change of 0.086116076 over the same period for the S&P500. Over the past 52 weeks, VYNE has reached a high of $4.30, while it has fallen to a 52-week low of $1.57. The 50-Day Moving Average of the stock is -29.70%, while the 200-Day Moving Average is calculated to be -25.85%.
Shares Statistics:
It appears that VYNE traded 106.67K shares on average per day over the past three months and 172790 shares per day over the past ten days. A total of 14.83M shares are outstanding, with a floating share count of 12.62M. Insiders hold about 17.02% of the company’s shares, while institutions hold 48.02% stake in the company. Shares short for VYNE as of 1740700800 were 123785 with a Short Ratio of 1.16, compared to 1738281600 on 123202. Therefore, it implies a Short% of Shares Outstanding of 123785 and a Short% of Float of 0.8200000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
